Cx Precision Medicine, Inc.

Cx Precision Medicine, Inc. Precision Medicine supports the recent federal court ruling blocking the FDA’s regulation of laboratory-developed tests (LDTs) as medical devices. This decision is a victory for innovation, patient access, and the future of precision diagnostics. CX Precision Medicine is advancing blood-based precision medicine tests that enable physicians to rule out neurodegenerative disorders such as Alzheimer’s Dementia and Parkinson’s Disease in age-appropriate patients with possible symptoms. These tests offer a non-invasive, accessible solutions for physicians to direct patients to targeted treatments. LDTs have long been regulated under the CMS CLIA program, ensuring quality while allowing for rapid advancements in medical science. This ruling reinforces the importance of smart regulation that fosters innovation without creating unnecessary barriers. https://lnkd.in/gFhHNJ4G

Thank you to the HBS Healthcare Alumni Association for featuring Danguole Altman, CEO of Cx Precision Medicine, Inc. in your spotlight profile. Your recognition of leaders driving innovation in healthcare is truly inspiring. We appreciate the HBS Healthcare Alumni community for fostering connections and sharing the stories of changemakers transforming patient care. #alzheimers #innovation #leadership https://lnkd.in/gBRFRuE9

Cx Precision Medicine, Inc. CEO Danguole Altman is wrapping up a fascinating trip to Davos World Economic Forum where she congratulates the Davos Alzheimer's Collaborative for sponsoring The Brain House. Conversations at The House focused on the importance of brain health over a lifespan, not only to the individual but to a successful economy. Another highlight was the talk by Takeda CEO Christophe Weber at the Axios and Lightspeed Venture Partners' panel on the Future of AI and Healthcare. #Davos #alzheimers #future

Cx Precision Medicine, Inc. CEO Danguole Altman is at The Brain House, part of the annual Davos World Economic Forum, where George Vradenburg, Chairman of the Davos Alzheimer's Collaborative is speaking. The Brain House is hosted by the Davos Alzheimer's Collaborative, where the world’s top experts in neuroscience, healthcare, and innovation come together to accelerate breakthroughs in the fight against Alzheimer's disease. A series of events happening Jan. 20-24 will feature leading experts in health and innovation who are advancing global brain health. The Davos Alzheimer’s Collaborative is a multi-stakeholder partnership committed to aligning stakeholders with a new vision for our collective global response against the challenges Alzheimer’s presents to patients, caregivers and healthcare infrastructures. Convened by The World Economic Forum and The Global CEO Initiative on Alzheimer’s Disease (CEOi) and fueled by a mission of service to the estimated 150 million families and half a billion people inevitably impacted by this disease by 2050, DAC is a collaborative for the benefit of all people, in all places. #TheBrainHouse #Davos2025 #alzheimers #leadership #innovation

Great to see this piece and congratulations to our Scientific Founder, Sid Obryant and team on creating this "unicorn" to ultimately help more people diagnose Alzheimer's Disease and find the care they need. #alzheimers #dementia https://lnkd.in/gz__dJAs

Cx Precision Medicine, Inc. CEO Danguole Altman reports from Boston: "So inspired seeing my Harvard 1981 classmate, HBS Professor Amy Edmondson, interview Sir Andrew Witty, CEO, UnitedHealth Group on the future of healthcare at the HBS Healthcare Alumni Association meeting. Discussing need for efficiency and individual empowerment paired with technology as powerful drivers of change in next decade and more. Fascinating discussion." Harvard Business School #healthcare #future

Thank you Fort Worth INC. for featuring us in your latest issue. We are proud to be part of the amazing #FortWorth and North Texas Biotech community. TechFW BioNTX Sid O’Bryant, Ph.D. University of North Texas Health Science Center College of Public Health Danguole Altman Darlene Boudreaux Carol Berry Heather Giles PhD, FBPharmacolS https://lnkd.in/gwhmxEsX

Thank You to StartUp Health for this excellent profile of Cx Precision Medicine, Inc. in the most recent issue of their Health Transformer Journal. CxPM is honored to be part of StartUp Health’s Alzheimer’s Moonshot Program which brings together innovative companies, research teams and stakeholders to accelerate progress in prevention, diagnosis and management of Alzheimer’s disease and related dementias. To learn more about CxPrecision Medicine visit our website: CxPrecisionM.com #dementia #alzheimers Danguole Altman Sid O’Bryant, Ph.D. https://lnkd.in/g9338FqA

Thanks to BioNTX for inviting Cx Precision Medicine, Inc. to participate in this week's 2024 iC³ Life Science & Healthcare Innovation Summit. Carol Berry, CxPM Chief Business Officer, made a company presentation before an attentive group of leaders from the dynamic North Texas bioscience and healthcare community. CxPM's NeuroFirst™ Memory test is the only blood-based test for primary care physicians use to rule out Alzheimer's Disease and related dementias, allowing doctors to triage which patients are unlikely to have dementia and should be evaluated and treated for other causes. CxPM's NeuroFirst™ Tests for AD are based on the extensive research and development led by Sid O’Bryant, Ph.D. at the University of North Texas Health Science Center College of Public Health. For more information visit: CxPrecisionM.Com #Dallas #Texas #alzheimers

Cx Precision Medicine, Inc. CEO Danguole Altman (right) with Phyllis Ferrell, Chief Impact Officer of StartUp Health's Alzheimers Moonshot Program, at the Lausanne XI Meeting sponsored by Davos Alzheimer's Collaborative and Us Against Alzheimers in Lausanne, Switzerland. Shown here on the terrace of the Olympic Museum at a reception hosted by the Global BHP BrainTrust. The Lausanne XI Meeting is a global gathering of leaders in government, pharma, advocacy groups, innovators and others, all focused on ending Alzheimer's Disease. #alzheimers #brainhealth Sid O’Bryant, Ph.D.